Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria
Obinna Onwujekwe(University of Nigeria), Paul O. Okonkwo(University of Nigeria), Viola Okoye(University of Nigeria Teaching Hospital), Harparkash Kaur(London School of Hygiene & Tropical Medicine), Nkem Dike(University of Nigeria), Kara Hanson(University of Colorado Anschutz Medical Campus), Elvis Shu(University of Nigeria), Benjamin Uzochukwu(University of Nigeria)
Cited by 118
Related Papers
Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper
|International Journal of Epidemiology|2012|613
Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction
|American Journal of Physiology-Heart and Circulatory Physiology|2000|396
The Lancet Nigeria Commission: investing in health and the future of the nation
|The Lancet|2022|346
Health care financing in Nigeria: Implications for achieving universal health coverage
|Nigerian Journal of Clinical Practice|2015|314
Interaction of bilirubin and biliverdin with reactive nitrogen species
|FEBS Letters|2003|208